Angiotensine II And NotHong D. Xiao

List of bibliographic references

Number of relevant bibliographic references: 12.

Ident.	Authors (with country if any)	Title
001763	RUI YANG [Belgique] ; Ilse Smolders [Belgique] ; Patrick Vanderheyden [Belgique] ; Heidi Demaegdt [Belgique] ; Ann Van Eeckhaut [Belgique] ; Georges Vauquelin [Belgique] ; Aneta Lukaszuk [Belgique] ; Dirk Tourwe [Belgique] ; Siew Yeen Chai [Australie] ; Anthony L. Albiston [Australie] ; Clara Nahmias [France] ; Thomas Walther [Royaume-Uni] ; Alain G. Dupont [Belgique, Allemagne]	Pressor and Renal Hemodynamic Effects of the Novel Angiotensin A Peptide Are Angiotensin II Type 1A Receptor Dependent
002329	Duncan J. Campbell [Australie] ; Habib Karam [France] ; Patrick Bruneval [France] ; John J. Mullins [Royaume-Uni] ; Joël Menard [France]	Increased dietary NaCl potentiates the effects of elevated prorenin levels on blood pressure and organ disease
002615	A. Koïtka [Australie] ; Z. Cao [Australie] ; P. Koh [Australie] ; A. M. D. Watson [Australie] ; K. C. Sourris [Australie] ; L. Loufrani [France] ; A. Soro-Paavonen [Australie] ; T. Walther [Royaume-Uni] ; K. J. Woollard [Australie] ; K. A. M. Jandeleit-Dahm [Australie] ; M. E. Cooper [Australie] ; T. J. Allen [Australie]	Angiotensin II subtype 2 receptor blockade and deficiency attenuate the development of atherosclerosis in an apolipoprotein E-deficient mouse model of diabetes
002911	Duncan J. Campbell [Australie] ; Habib Karam [France] ; Joël Menard [France] ; Patrick Bruneval [France] ; John J. Mullins [Royaume-Uni]	Prorenin Contributes to Angiotensin Peptide Formation in Transgenic Rats With Rat Prorenin Expression Targeted to the Liver
004572	DONG YOU [France] ; Laurent Loufrani [France] ; Celine Baron [France] ; Bernard I. Levy [France] ; Robert E. Widdop [Australie] ; Daniel Henrion [France]	High blood pressure reduction reverses angiotensin II type 2 receptor-mediated vasoconstriction into vasodilation in spontaneously hypertensive rats
005300	Victor J. Dzau [États-Unis] ; Kenneth Bernstein [États-Unis] ; David Celermajer [Australie] ; Jerome Cohen [États-Unis] ; Björn Dahlöf [Suède] ; John Deanfield [Royaume-Uni] ; Javier Diez [Espagne] ; Helmut Drexler [Allemagne] ; Roberto Ferrari [Italie] ; Wiek Van Gilst [Pays-Bas] ; Lennart Hansson [Suède] ; Burkhard Hornig [Allemagne] ; Ahsan Husain [Australie] ; Colin Johnston [Australie] ; Harold Lazar [États-Unis] ; Eva Lonn [Canada] ; Thomas Lüscher [Suisse] ; John Mancini [Canada] ; Albert Mimran [France] ; Carl Pepine ; Ton Rabelink ; Willem Remme ; Luis Ruilope ; Marcel Ruzicka ; Heribert Schunkert ; Karl Swedber ; Thomas Unger ; Douglas Vaughan ; Michael Weber	Pathophysiologic and therapeutic importance of tissue ACE: A consensus report
005552	Robert E. Widdop [Australie] ; Khalid Matrougui [France] ; Bernard I. Levy [France] ; Daniel Henrion [France]	AT2 receptor-mediated relaxation is preserved after long-term AT1 receptor blockade
005B67	F. Bonnet [Australie, France] ; M. E. Cooper [Australie]	Potential influence of lipids in diabetic nephropathy : Insights from experimental data and clinical studies
006861	R. S. Weisinger [Australie] ; J. R. Blair-West [Australie] ; P. Burns [Australie] ; D. A. Denton [Australie] ; M. J. Mckinley [Australie] ; E. Tarjan [Australie]	The role of angiotensin II in ingestive behaviour : a brief review of angiotensin II, thirst and Na appetite
006886	A. Penhoat [France] ; R. Ouali [France] ; I. Viard [France] ; D. Langlois [France] ; J. M. Saez [France]	Regulation of primary response and specific genes in adrenal cells by peptide hormones and growth factors
006973	M. J. Mckinley [Australie] ; M. L. Mathai [Australie]	Centrally administered losartan inhibits the reduction in plasma renin concentration caused by intracerebroventricular hypertonic saline in Na-depleted sheep
006D11	H. R. Brunner [Suisse] ; J. Nussberger ; M. Burnier ; B. Waeber	Angiotensin II antagonists

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024